{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:56:36Z","timestamp":1781931396897,"version":"3.54.5"},"reference-count":44,"publisher":"Codon Publications","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007841","name":"Research Council of Trakya University","doi-asserted-by":"publisher","award":["TUBAP-2009\/157"],"award-info":[{"award-number":["TUBAP-2009\/157"]}],"id":[{"id":"10.13039\/100007841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.aller.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T12:01:25Z","timestamp":1564488085000},"page":"339-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum soluble Fas ligand levels and peripheral blood lymphocyte subsets in patients with drug-induced maculopapular rashes, dress, and viral exanthemas"],"prefix":"10.15586","volume":"48","author":[{"given":"M.","family":"Yazicioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gokmirza Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2019.02.003_bib0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1399-3038.2007.00592.x","article-title":"Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren","volume":"19","author":"Orhan","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/all.12774","article-title":"Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group","volume":"71","author":"Gomes","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2019.02.003_bib0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tox.2004.12.023","article-title":"Drug-induced exanthems","volume":"209","author":"Yawalkar","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.aller.2019.02.003_bib0240","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00130832-200410000-00013","article-title":"The immunological and clinical spectrum of delayed drug-induced exanthems","volume":"4","author":"Lerch","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/DER.0b013e318280cbe5","article-title":"Drug- and virus- or bacteria-induced exanthems: the role of immunohistochemical staining for cytokines in differential diagnosis","volume":"24","author":"Bellini","year":"2013","journal-title":"Dermatitis"},{"key":"10.1016\/j.aller.2019.02.003_bib0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1079-9796(03)00004-4","article-title":"Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children","volume":"30","author":"Torres","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.aller.2019.02.003_bib0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000024271","article-title":"Distinct serum cytokine levels in drug- and measles-induced exanthema","volume":"120","author":"Hari","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0260","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8010-9","article-title":"A complex interaction between drug allergy and viral infection","volume":"33","author":"Shiohara","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0265","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1398-9995.2007.01518.x","article-title":"Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation?","volume":"62","author":"Jappe","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2019.02.003_bib0270","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1542\/peds.2012-1575","article-title":"Incidence of rash after amoxicillin treatment in children with infectious mononucleosis","volume":"131","author":"Chovel-Sella","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.aller.2019.02.003_bib0275","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6: reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2019.02.003_bib0280","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2019.02.003_bib0285","first-page":"80","article-title":"Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests","volume":"19","author":"Torres","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0290","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2019.02.003_bib0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2019.02.003_bib0300","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.jid.5700648","article-title":"Soluble FAS ligand: a discriminating feature between drug-induced skin eruptions and viral exanthemas","volume":"127","author":"Stur","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.aller.2019.02.003_bib0305","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2019.02.003_bib0310","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.iac.2009.04.008","article-title":"Provocation tests in drug hypersensitivity","volume":"29","author":"Aberer","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.aller.2019.02.003_bib0315","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) \u2013 classification, diagnosis and management: review of the EAACI\/ENDA(#) and GA2LEN\/HANNA*","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2019.02.003_bib0320","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.iac.2009.04.010","article-title":"Skin testing in delayed reactions to drugs","volume":"29","author":"Barbaud","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.aller.2019.02.003_bib0325","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 72","key":"10.1016\/j.aller.2019.02.003_bib0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1398-9995.57.s72.7.x","article-title":"Drug allergy diagnosis work up","volume":"57","author":"Demoly","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2019.02.003_bib0335","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2010.03.010","article-title":"Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy","volume":"104","author":"Mori","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0340","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7326\/0003-4819-140-12-200406150-00009","article-title":"Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction","volume":"140","author":"Messaad","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aller.2019.02.003_bib0345","first-page":"125","article-title":"Peripheral blood lymphocyte subsets in healthy Turkish children","volume":"46","author":"Ikincio\u011fullari","year":"2004","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.aller.2019.02.003_bib0350","series-title":"Nelson text book of pediatrics","first-page":"3464","article-title":"Reference intervals for laboratory tests and procedures","author":"Lo","year":"2016"},{"key":"10.1016\/j.aller.2019.02.003_bib0355","unstructured":"Common cutaneous drug reactions \u2013 BMJ. bp.api.bmj.com\/best-practice\/monograph-pdf\/368.pdf."},{"issue":"Suppl. 2","key":"10.1016\/j.aller.2019.02.003_bib0360","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy","volume":"125","author":"Khan","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0365","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1067\/mai.2000.109828","article-title":"Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction","volume":"106","author":"Posadas","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0370","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2002.120563","article-title":"Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity","volume":"109","author":"Posadas","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0375","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.aller.2019.02.003_bib0380","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.aller.2019.02.003_bib0385","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaci.2008.06.013","article-title":"Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment","volume":"122","author":"Murata","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0390","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00130832-200108000-00004","article-title":"Immunohistology of drug-induced exanthema: clues to pathogenesis","volume":"1","author":"Yawalkar","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0395","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aller.2019.02.003_bib0400","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20121517","article-title":"Revealing the role of CD4(+) T cells in viral immunity","volume":"209","author":"Sant","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.aller.2019.02.003_bib0405","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(00)03137-8","article-title":"Idiosyncratic drug reactions: the reactive metabolite syndromes","volume":"356","author":"Knowles","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.aller.2019.02.003_bib0410","first-page":"301","article-title":"Association of human herpesvirus 6 infection with drugreaction with eosinophilia and systemic symptoms","volume":"137","author":"Descamps","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2019.02.003_bib0415","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1399-3038.2011.01183.x","article-title":"Educational case series: mechanisms of drug allergy","volume":"22","author":"Caubet","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0420","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2019.02.003_bib0425","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tox.2004.12.011","article-title":"Innate immunity and hypersensitivity syndrome","volume":"209","author":"Inaoka","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.aller.2019.02.003_bib0430","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.4049\/jimmunol.167.11.6132","article-title":"Human B cell activation by autologous NK cells is regulated by CD40\u2013CD40 ligand interaction: role of memory B cells and CD5+ B cells","volume":"167","author":"Blanca","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0435","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1081-1206(10)60273-6","article-title":"Phenytoin-induced DRESS","volume":"103","author":"Yazicioglu","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.aller.2019.02.003_bib0440","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-3038.2012.01268.x","article-title":"The association between DRESS and the diminished numbers of peripheral B lymphocytes and natural killer cells","volume":"23","author":"Yazicioglu","year":"2012","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054619300424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054619300424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T13:50:09Z","timestamp":1721569809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054619300424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0301054619300424"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2019.02.003","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum soluble Fas ligand levels and peripheral blood lymphocyte subsets in patients with drug-induced maculopapular rashes, dress, and viral exanthemas","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SEICAP. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}